Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Positive

Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Positive

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2232https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2232
Retrieved on: 
Tuesday, April 9, 2024
Information
Tags: 
Eurostat, Civil service commission, Diagnosis, DSM-IV codes, Brain, Disease, ALS, Paralysis, Nervous system, Patient, Committee, Knowledge, Lactiplantibacillus plantarum, Regulation, Bacteria, EMA, IRIS, Death, Respiratory failure, Woman, Saliva, European, COMP, Spinal cord, Safety, European Commission, MDC, Riluzole, Marketing, Hand, Medicine, Pharmaceutical industry
Geotags: 
EUROPEAN UNION, RARE, EC, ICELAND, EU, LIECHTENSTEIN, NORWAY, GERMANY, UNITED STATES
Summary
Key Points: 


Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Positive

Copyright: 
2024 European Medicines Agency. All Rights Reserved.